4.605
Ensayos registrados
583
Reclutando activamente
21
Especialidades
1
Fuentes de datos
ReclutandoFase 3ClinicalTrials.gov
EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%
INTERVENTIONALInicio: 20 de may de 2025ID: NCT06935370
ReclutandoFase 2ClinicalTrials.gov
An Open Label, Dose Range, Proof-of-Concept Study to Assess the Safety and Efficacy of HM15421/GC1134A in Patients With Fabry Disease
INTERVENTIONALInicio: 14 de may de 2025ID: NCT06858397
ReclutandoFase 3ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Orforglipron on the Incidence of Major Adverse Cardiovascular Events in Participants With Established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
INTERVENTIONALInicio: 1 de dic de 2025ID: NCT07241390
ReclutandoFase 3ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK-3543) Versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants
INTERVENTIONALInicio: 16 de jul de 2024ID: NCT06456346
ReclutandoClinicalTrials.gov
Cardiometabolic Risk Factors Registry
OBSERVATIONALInicio: 1 de jun de 2015ID: NCT04040777
ReclutandoClinicalTrials.gov
A Registry of Spontaneous Coronary Artery Dissection
OBSERVATIONALInicio: 30 de ene de 2021ID: NCT06601270
Explorar por especialidad
Encuentra ensayos clinicos relevantes para tu area de practica.